CJC-1295 With DAC Vials
|CJC – 1295 DAC Peptide|
|Molar Mass||3367.954 g·mol−1|
|IUPAC Name||CJC 1295 (DAC-GRF)|
CJC-1295 With Dac is a peptide designed exclusively for research purposes. This peptide is of interest to researchers investigating its potential impact on growth hormone release and related factors.
CJC-1295 With Dacis known for its extended half-life due to the addition of Drug Affinity Complex (Dac), potentially leading to prolonged effects on growth hormone release.
This research peptide is formulated for scientific investigations aiming to understand the properties and effects of CJC-1295 With Dac. Researchers may explore its applications in various research models.
CJC-1295 and Growth Hormone
Studies suggest that CJC-1295 With Dac may stimulate the release of growth hormone, which could be of interest to researchers exploring its impact on physiological processes.
CJC-1295 and IGF-1
Research may focus on the potential relationship between CJC-1295 and insulin-like growth factor 1 (IGF-1), as IGF-1 is often associated with growth hormone activity.
CJC-1295 and GH Deficiency
Researchers may investigate whether CJC-1295 With Dac holds promise in addressing growth hormone deficiency, potentially contributing to therapeutic advancements.
CJC-1295 With Dac is a research peptide designed for scientific exploration into its impact on growth hormone release and related factors. Researchers are encouraged to investigate its applications and potential benefits in various research models.
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. doi: 10.1210/jc.2005-1536. Epub 2005 Dec 13. PMID: 16352683. [Read More].
- Clemmons DR. Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency. Horm Res. 2007;68 Suppl 5:178-81. doi: 10.1159/000110620. Epub 2007 Dec 10. PMID: 18174751. [Read More].